|
Q4 FY2014
As of Dec 31, 2014
|
Q3 FY2014
As of Sep 30, 2014
|
Q2 FY2014
As of Jun 30, 2014
|
Q1 FY2014
As of Mar 31, 2014
|
Q4 FY2013
As of Dec 31, 2013
|
Q3 FY2013
As of Sep 30, 2013
|
Q2 FY2013
As of Jun 30, 2013
|
Q1 FY2013
As of Mar 31, 2013
|
Q4 FY2012
As of Dec 31, 2012
|
Q3 FY2012
As of Sep 30, 2012
|
Q2 FY2012
As of Jun 30, 2012
|
Q1 FY2012
As of Mar 31, 2012
|
Q4 FY2011
As of Dec 31, 2011
|
Q3 FY2011
As of Sep 30, 2011
|
Q2 FY2011
As of Jun 30, 2011
|
Q1 FY2011
As of Mar 31, 2011
|
Q4 FY2010
As of Dec 31, 2010
|
Q3 FY2010
As of Sep 30, 2010
|
Q2 FY2010
As of Jun 30, 2010
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||||||||||
| Current assets: | |||||||||||||||||||
| Cash and cash equivalents | |||||||||||||||||||
| Restricted cash | |||||||||||||||||||
| Marketable securities | |||||||||||||||||||
| Accounts receivable, net | |||||||||||||||||||
| Inventories | |||||||||||||||||||
| Deferred income tax benefit | |||||||||||||||||||
| Prepaid expenses and other current assets | |||||||||||||||||||
| Total current assets | |||||||||||||||||||
| Property, plant and equipment, net | |||||||||||||||||||
| Intangible assets, net | |||||||||||||||||||
| Goodwill | |||||||||||||||||||
| Deferred income tax benefit | |||||||||||||||||||
| Other assets | |||||||||||||||||||
| Total assets | |||||||||||||||||||
| Liabilities and Equity | |||||||||||||||||||
| Liabilities | |||||||||||||||||||
| Current liabilities: | |||||||||||||||||||
| Trade accounts payable | |||||||||||||||||||
| Short-term borrowings | |||||||||||||||||||
| Income taxes payable | |||||||||||||||||||
| Current portion of long-term debt and other long-term obligations | |||||||||||||||||||
| Deferred income tax liability | |||||||||||||||||||
| Other current liabilities | |||||||||||||||||||
| Total current liabilities | |||||||||||||||||||
| Long-term debt | |||||||||||||||||||
| Contingent consideration | |||||||||||||||||||
| Other long-term obligations | |||||||||||||||||||
| Deferred income tax liability | |||||||||||||||||||
| Total liabilities | |||||||||||||||||||
| Equity | |||||||||||||||||||
| Mylan Inc. shareholders’ equity | |||||||||||||||||||
| Common stock — par value $0.50 per share | |||||||||||||||||||
| Additional paid-in capital | |||||||||||||||||||
| Retained earnings | |||||||||||||||||||
| Accumulated other comprehensive loss | |||||||||||||||||||
| Total Mylan Inc. shareholders' equity | |||||||||||||||||||
| Total Mylan Inc. shareholders' equity, before treasury stock | |||||||||||||||||||
| Noncontrolling interest | |||||||||||||||||||
| Less: Treasury stock — at cost | |||||||||||||||||||
| Total equity | |||||||||||||||||||
| Total liabilities and equity | |||||||||||||||||||
Loading...
